Centro Hospitalar do Funchal, Funchal, Portugal.
Centro Hospitalar do Funchal, Funchal, Portugal.
Am J Otolaryngol. 2021 Jan-Feb;42(1):102825. doi: 10.1016/j.amjoto.2020.102825. Epub 2020 Nov 4.
The aim of this study was to evaluate the 4-year outcomes and effectiveness of balloon sinuplasty in the treatment of chronic rhinosinusitis (CRS).
We evaluated the long-term outcomes in terms of symptoms, nasal endoscopy and computed tomography of 110 patients with CRS submitted to balloon sinuplasty in Centro Hospitalar do Funchal retrospectively. Sinus symptoms were determined by the Sino-Nasal Outcome Test (SNOT-22), endoscopic examination determined by Modified Lund Kennedy score (MLK) and computerized tomography scan of paranasal sinuses (CT-PNS) was evaluated through Lund Mackay scores (LM). Data was collected from 82 patients with chronic rhinosinusitis without nasal polyps (CRSsNP) and from 28 patients with nasal polyps (CRSwNP).
Local anesthesia procedures were performed in 45.5% of the patients. First follow up was obtained at 2 years (median 22.45 ± 13.6 months) and at 4 years (median 44.45 ± 14 months) after balloon sinuplasty. The mean baseline SNOT-22 score was of 50.26 ± 15.33 for patients with CRSsNP and 52.25 ± 18.06 in CRSsNP patients. Both scores were reduced to 7.00 ± 13.5 and 10.00 ± 22.50 at 4 years follow-up respectively. Baseline MLK score was 4.90 ± 2.12 for patients in CRSsNP group and 10.00 ± 2.00 in the CRSwNP group Both scores were reduced to 1.65 ± 1.67 and 4.86 ± 2.16. The overall mean average LM CT-PNS score was 8.71 ± 4.728 preoperatively for the CRSsNP and 16.18 ± 3.9 in patients with CRSwNP and were reduced to 1.00 ± 1.75 and 8.69 ± 4.6 after BSP. SNOT 22, MLK and LM scores showed consistent improvement over baseline at all time points until the end of the study (median 44.45 ± 14 months). Significant improvements were recorded at all time points in the patient's symptom score, nasal endoscopy scores and imaging scores (P < 0.0001).
Balloon sinuplasty appears to be safe and effective for the treatment of CRS with great long-term outcomes.
本研究旨在评估鼻窦球囊扩张术治疗慢性鼻-鼻窦炎（CRS）的 4 年疗效。
我们回顾性分析了 110 例接受鼻窦球囊扩张术治疗的 CRS 患者的长期疗效，包括症状、鼻内镜和鼻窦计算机断层扫描（CT）。鼻窦症状采用 Sino-Nasal Outcome Test（SNOT-22）评估，内镜检查采用改良 Lund Kennedy 评分（MLK），鼻窦 CT 扫描采用 Lund-Mackay 评分（LM）。数据来自 82 例无鼻息肉的慢性鼻-鼻窦炎患者（CRSsNP）和 28 例鼻息肉患者（CRSwNP）。
45.5%的患者采用局部麻醉。术后 2 年（中位数 22.45±13.6 个月）和 4 年（中位数 44.45±14 个月）进行首次随访。CRSsNP 患者的基线 SNOT-22 评分为 50.26±15.33，CRSwNP 患者为 52.25±18.06。4 年随访时，两组评分分别降至 7.00±13.5 和 10.00±22.5。CRSsNP 患者的基线 MLK 评分为 4.90±2.12，CRSwNP 患者为 10.00±2.00。两组评分均降至 1.65±1.67 和 4.86±2.16。CRSsNP 患者的总体平均 LM CT-PNS 术前评分为 8.71±4.728，CRSwNP 患者为 16.18±3.9，BSP 后分别降至 1.00±1.75 和 8.69±4.6。SNOT 22、MLK 和 LM 评分在所有时间点均较基线持续改善，直至研究结束（中位数 44.45±14 个月）。患者症状评分、鼻内镜评分和影像学评分在所有时间点均有显著改善（P<0.0001）。
鼻窦球囊扩张术治疗 CRS 安全有效，长期疗效好。
Zotero 插件